The intestine is not just a digestive organ. In recent years, it has fascinated as much as it has raised questions, as its links with the immune system have proven to be complex. At the intersection of genetics, the environment and the microbiota, certain chronic diseases find a favorable, but still poorly understood, terrain. It is in this cellular labyrinth that science is finally progressing, and beginning to decipher the precise mechanisms behind reactions to gluten.
This attack causes damage to the intestinal villi, these microstructures responsible for absorbing nutrients. In the long term, the body struggles to assimilate iron, calcium, or even vitamin B12, which can lead to serious complications such as osteoporosis, neurological disorders or persistent anemia. The Celiac Disease Foundation points out that more than 200 different symptoms have been identified, and that the disease can remain silent for years, while causing progressive deterioration of the intestinal mucosa.
The only basic treatment recognized so far consists of adopting a strict gluten-free diet for life. But this lifestyle does not always prevent immune reactions, particularly in the event of cross-contamination or accidental exposure. This persistent vagueness about the triggering mechanisms leaves many patients in uncertainty.
What Science Finally Reveals About Gluten Reactions
A turning point may have just begun thanks to the work carried out by a Canadian team from McMaster University, in collaboration with other international research centers. Published in the journal Gastroenterology, their study sheds light on one of the first stages of the immune reactions involved in celiac disease. Until then, researchers knew that certain gluten fragments managed to cross the intestinal barrier, but the role of the cells lining this barrier remained poorly understood.
By deriving intestinal cells from transgenic mice carrying the human HLA-DQ2.5 gene – strongly associated with the disease – the researchers produced organoids, a living structure copying the human intestines. They then subjected them to inflammatory stimuli and different types of gluten, some predigested by bacterial enzymes, others left intact. Verdict: the cells of the intestinal wall are not simple collateral victims. They play an active role by capturing gluten fragments and presenting them directly to the immune system, via HLA proteins, thus triggering the activation of T lymphocytes.
According to biomedical engineer Tohid Didar cited by ScienceAlert, this method made it possible to precisely establish the causal chain, confirming the direct link between intestinal cells, local inflammation and the occurrence of immune reactions. The study also highlights that the digestion of gluten by certain gut bacteria, such as Pseudomonas aeruginosaworsens this presentation, making the fragments even more easily recognizable by cells of the immune system – in this experimental context.
Towards treatments capable of soothing the intestine without excluding gluten
This discovery opens up new perspectives in the management of the disease. Rather than aiming solely to eliminate gluten, researchers are now considering directly targeting the intestinal cells responsible for this antigenic presentation. Acting on these cells or on the enzymes that facilitate the transport of gluten fragments would theoretically make it possible to reduce or even interrupt the immune reaction at its source, even before it begins.
This would represent a major paradigm shift. Until now, the entire therapeutic strategy was based on dietary constraints. But according to gastroenterologist Elena Verdu, a member of the McMaster team, a gluten-free diet is not always enough to prevent chronic inflammation or fully restore intestinal integrity. For many patients, even a little gluten in a dish can be enough to restart inflammation in the most sensitive.
By making intestinal epithelial cells less likely to participate in the immune alert, future treatments could restore some food tolerance to patients. This does not mean the immediate end of the gluten-free diet, but a step towards a more modular treatment model, where the body's defense mechanisms would stop turning against itself at the slightest contact with this protein.
